스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - fentanylum - cerotto transdermico - fentanylum 2.1 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: orange, ad praeparationem pro 5.25 cm² cum liberatione 12.5 µg/h. - analgesico - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - topiramatum - capsule - topiramatum 15 mg, sacchari sphaerae, povidonum k 30, cellulosi acetas, kapselhülle: gelatina, e 171 pro capsula. - farmaco antiepilettico, migräneprophylaxe - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - topiramatum - capsule - topiramatum 50 mg, sacchari sphaerae, povidonum k 30, cellulosi acetas, kapselhülle: gelatina, e 171 pro capsula. - farmaco antiepilettico, migräneprophylaxe - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - diphenhydramini hydrochloridum, codeini phosphas hemihydricus - sirup - diphenhydramini hydrochloridum 14 mg, codeini phosphas hemihydricus 5.7 mg, levomentholum, saccharum 999 mg, glucosum liquidum 3.49 g, ethanolum 96 per centum 0.259 ml, glycerolum, natrii citras dihydricus, saccharinum natricum, acidum citricum monohydricum, aqua purificata, aromatica, e 124 0.25 mg, e 150(a), e 211 10 mg ad solutionem pro 5 ml corresp. ethanolum 5 % v/v et natrium 16.65 mg. - tosse stizzosa - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 6.5 mg, hypromellosum, e 171, triacetinum, e 172 (flavum), acidum stearicum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 16.7 mg, hypromellosum, e 171, triacetinum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 7.6 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), e 172 (flavum), macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 4.9 mg, hypromellosum, e 171, triacetinum, e 172 (nigrum), macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - galantaminum - capsule - galantaminum 8 mg per galantamini hydrobromidum, zucchero sfere corrisp. sintetico 50.9-58.21 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, kapselhülle: gelatina, e-171, drucktinte: lacca, propylenglycolum, e 172 (nero), una piccola scatola. - da lieve a moderata demenza da malattia di alzheimer di tipo - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - galantaminum - capsule - galantaminum 16 mg per galantamini hydrobromidum, zucchero sfere corrisp. sintetico 101.8-116.43 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, kapselhülle: gelatina, e-171, e-172 (rosso), drucktinte: lacca, propylenglycolum, e 172 (nero), una piccola scatola. - da lieve a moderata demenza da malattia di alzheimer di tipo - synthetika